PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Media Alert: American College of Cardiology to host Sports Cardiology Conference

ACC Care of the Athletic Heart highlights latest advances in the field of sports cardiology

2023-06-02
(Press-News.org) The American College of Cardiology will host the annual Care of the Athletic Heart course on June 8-10, 2023, in Washington, including poster abstracts and educational sessions. The course is designed for all clinicians who provide cardiovascular care for the professional, occupational, tactical or recreational athlete. As the athletic population expands to all demographic groups, it is critical that there is a larger contingent of clinicians who understand the latest care and practice management for athletes at every level.

Dermot Phelan, BAO, MBBCh, PhD, FACC, and Megan Wasfy, MD, FACC, will serve as the course chair and vice chair respectively. The course, which will be available both in-person and online, will feature top sports cardiology experts discussing the latest advances in sports cardiology, as well as fundamental cardiovascular diagnostic and management strategies and treatment options in the field.

Can’t Miss Sessions:

Keynote: Can the Heart Get a Sports Injury? Participation Screening: The Debate Continues Debate Topics: Are We Really Still Having This Debate? ECG vs. No ECG for Preparticipation Screening of Young Competitive Athletes I’m 50 and I’ve Decided to Run a Marathon – Should I Undergo Preparticipation Screening for Coronary Disease? Strategies for Engaging the Community in CPR and AED Training Legal and Ethical Considerations for Shared Decision Making for Sporting Participation in an Athlete with Cardiac Disease From the Ocean to the Mountain Top – Environmental Considerations for the Athlete with Heart Disease Posters

The following abstract titles are a selection of posters being presented during the conference. All ACC Care of the Athletic Heart posters and clinical case challenges are embargoed until Thursday, June 8, 2023, at 12 p.m. ET.

Who Performs Cardiopulmonary Resuscitation During Sports-Related Sudden Cardiac Arrest in Athletes? Return to Play Evaluation Post COVID – Longitudinal Experience in Cardiac Risk Assessment at a Division I Athletic Program Outcomes and Results of 10 Years of Cardiac Screening of Elite New Zealand Athletes Cardiovascular Screening of Tactical Athletes: Results from ECG Screening of Cadets and Midshipmen at Military Service Academies COACH Study: COVID-19 Influence on Athletic Cardiopulmonary Health Assessed as the Change in VO2max: a Systematic Review and Meta-Analysis If members of the media would like to receive embargoed copies of these abstracts or register for media access to the conference, contact ACC Associate Director for Media Relations Katie Glenn at kglenn@acc.org.

The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. As the preeminent source of professional medical education for the entire cardiovascular care team since 1949, ACC credentials cardiovascular professionals in over 140 countries who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. Through its world-renowned family of JACC Journals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring a world where science, knowledge and innovation optimize patient care and outcomes. Learn more at www.ACC.org or follow @ACCinTouch.

###

END



ELSE PRESS RELEASES FROM THIS DATE:

Immunotherapy for brain cancer metastases shows clinical benefit

2023-06-02
In a phase 2 clinical trial of the immune checkpoint inhibitor pembrolizumab, investigators found that 42 percent of patients with metastatic brain cancer benefited from the therapy, with seven patients in the trial surviving longer than two years. The authors caution that these benefits must be weighed against risk of toxicity, but, overall, the study shows promising results that warrant larger studies and efforts to identify patients most likely to benefit from this treatment. Their findings are published in Nature Medicine and presented simultaneously at the 2023 ASCO Annual Meeting on June 2. “There ...

Commentary calls for equal access to healthcare for DACA recipients and all immigrants

2023-06-02
The paper, published April 17 in The Lancet Regional Health – Americas, was co-authored by Dr. Gunisha Kaur, an associate professor of anesthesiology at Weill Cornell Medicine and medical director of the Weill Cornell Center for Human Rights; Stephen Yale-Loehr, a professor of immigration law practice at Cornell Law School; and Jin K. Park, a medical student at the Harvard School of Medicine and the first DACA recipient awarded a Rhodes Scholarship. “The erratic enforcement of the DACA program since its inception has led many immigrants and their families to disengage completely from the healthcare system to avoid risking deportation,” said ...

Taming a frenzied immune system

Taming a frenzied immune system
2023-06-02
Researchers at the University of Louisville have received $5.8 million in two grants from the National Institutes of Health to expand their work to better understand and prevent immune system dysregulation responsible for acute respiratory distress, the condition responsible for serious illness and death in some COVID-19 patients. A separate $306,000 NIH Small Business Innovation Research grant supports early testing of a compound developed at UofL as a potential treatment. The three grants combined total $6.1 million. During the pandemic, health care providers worked tirelessly to treat patients ...

Veterans exposed to Agent Orange may be at increased risk of developing progressive blood cancers

2023-06-02
WASHINGTON --- Research conducted at Georgetown University’s Lombardi Comprehensive Cancer Center and the Washington DC VA Medical Center on a database of veterans exposed to Agent Orange found an association for an increased risk of developing myeloproliferative neoplasms (MPNs), which are acquired stem cell disorders that can lead to overproduction of mature blood cells complicated by an increased risk of blood clots in arteries and veins. When MPNs progress, they can become deadly leukemias. The findings will be presented at the American Society of Clinical Oncology 2023 annual meeting in Chicago in June. Agent Orange is an herbicide that was utilized by the United States military ...

Hispanic women still at higher risk for births with neural tube defects after voluntary folic acid fortification of corn masa flour

2023-06-02
The US Food and Drug Administration (FDA) mandated folic acid fortification of all enriched cereal grains in 1996, and this regulation resulted in a reduction of neural tube defect (NTD)–affected pregnancies for the population in the United States. While this mandatory food fortification strategy is an example of a public health success, Hispanic women in the US continued to be twice as likely to give birth to a child affected by NTD compared to non-Hispanic women. It was not until the year 2016 that the FDA approved voluntary, but not mandatory, folic acid fortification for corn masa flour products in the US to focus on the Hispanic diet staples, such ...

Buckle up! A new class of materials is here

2023-06-02
Usually, the two characterizations of a material are mutually exclusive: something is either stiff, or it can absorb vibrations well – but rarely both. However, if we could make materials that are both stiff and good at absorbing vibrations, there would be a whole host of potential applications, from design at the nano-scale to aerospace engineering. Buckling does the trick A team of researchers from the University of Amsterdam has now found a way to create materials that are stiff, but still good at absorbing vibrations – and equally importantly, that can be kept very light-weight. David Dykstra, lead author of the ...

Lupus Therapeutics partners to evaluate potential treatment for SLE and lupus nephritis through North American trial network

2023-06-02
NEW YORK, N.Y. — June 2. Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical trials testing an investigational therapeutic ianalumab for systemic lupus erythematosus and lupus nephritis.  Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, will help Novartis Pharmaceuticals Corporation (Novartis) conduct the trials through the Lupus Clinical Investigators Network (LuCIN) at top academic centers throughout North America. Lupus is a devastating heterogeneous autoimmune disease affecting millions worldwide with symptoms that can range from debilitating fatigue to ...

Sensory adaptations to improve physiological, behavioral distress during dental visits in autistic children

2023-06-02
About The Study: In this randomized crossover trial of autistic children, using a sensory-adapted dental environment was safe and efficacious in decreasing physiological and behavioral distress during dental care. This is important because enhancing oral care is critical for autistic children; this intervention may also be beneficial for populations beyond autism.  Authors: Leah I. Stein Duker, Ph.D., O.T.R./L., of the University of Southern California in Los Angeles, is the corresponding author.   To access the embargoed study: Visit our For The Media website ...

Awareness of racial, ethnic bias and potential solutions to address bias with use of health care algorithms

2023-06-02
About The Study: This qualitative study found that participants perceived widespread and increasing use of algorithms in health care and lack of oversight, potentially exacerbating racial and ethnic inequities. Increasing awareness for clinicians and patients and standardized, transparent approaches for algorithm development and implementation may be needed to address racial and ethnic biases related to algorithms.  Authors: Peter Treitler, M.S.W., of Rutgers University in New Brunswick, New Jersey, is the corresponding author. To ...

Reentry services may help stabilize substance use risks after mass prison release

2023-06-02
Contrary to expectations, the risk for relapses, overdoses and deaths related to substance use disorder didn’t increase after a large-scale prison release in New Jersey, according to a Rutgers study.   The study, published in JAMA Health Forum, examined whether post-release overdose deaths and drug-related hospital and emergency department visits increased after more than 2,000 individuals were released from prison in late 2020 as the result of a pandemic-era policy.   “Risk of relapse and adverse health events is high following prison release, with risk of fatal overdose ...

LAST 30 PRESS RELEASES:

Study finds senescent immune cells promote lung tumor growth

Study examines benefits and obstacles of library data storytelling

Cost of living crisis set to cut UK lives short and significantly widen wealth-health gap

Flawed body of research indicates true ‘long COVID’ risk likely exaggerated

Wealthier kids in UK may have experienced steepest fall in mental health during pandemic

Stem cell therapy can safely slow progression of relapsing-remitting MS

NASA’s Interstellar Mapping and Acceleration Probe passes system integration review

National Science Foundation taps Worcester Polytechnic Institute fire protection expertise and resources for the Wildfire Interdisciplinary Research Center

Doctor and pharmacist revamp standard processes for ordering and documenting mifepristone use

Screening for adverse childhood experience can improve trauma-informed care, though time constraints and limited referral resources present challenges

Understanding parents’ care expectations for a child with gastroenteritis could prevent after-hours care requests

Learning collaborative promotes mifepristone education and utilization training in federally qualified health centers

Men who trust their doctors, receive adequate time and general information about prostate cancer screening are more likely to have productive discussions

Study identifies patient and clinician-level characteristics associated with sexual history screening administration

Researchers identify important strategies for diabetes care and quality improvements in the primary care setting

Attentiveness to resting leg cramps may afford greater insight into advancing age and declining health

Staffing challenges and general time constraints may harm primary care teams’ ability to implement quality improvement efforts

Primary care investigators, clinicians, patients and community members reflect on NAPCRG’s 50 years of leadership and service

September/October Annals of Family Medicine 2023 tip sheet

Combination radiation with immunotherapy shows promise against “cold” breast cancer tumors

A new AI model has been developed to improve accuracy of breast cancer tumor removal

Finding the balance: Opioids and pain control after surgery

UC Irvine scientists reveal what fuels wildfires in Sierra Nevada Mountains

US Department of Energy Office of Science awards $115M for High Rigidity Spectrometer project at FRIB

Algorithm would predict disease relapses

Exercise-mimicking drug sheds weight, boosts muscle activity in mice

Did life exist on Mars? Other planets? With AI's help, we may know soon

Wind energy projects in North America are more likely to be opposed by white, wealthy communities

Naming and shaming can be effective to get countries to act on climate

Scientists develop method of identifying life on other worlds

[Press-News.org] Media Alert: American College of Cardiology to host Sports Cardiology Conference
ACC Care of the Athletic Heart highlights latest advances in the field of sports cardiology